Image of ACCESS TO MEDICINES : EXPERIENCES WITH COMPULSORY LICENSES AND GOVERNMENT USE - THE CASE OF HEPATITIS C

Artikel

ACCESS TO MEDICINES : EXPERIENCES WITH COMPULSORY LICENSES AND GOVERNMENT USE - THE CASE OF HEPATITIS C

This South Centre research paper discusses first, the limitations of the current research and development (R&D) model and its implications for access to medicines. Second, it considers the tension between intellectual property rights applied to medicines and States' observance of the fundamental right to health. Third, it examines the case of access to medicines for the treatment of Hepatitis C, illustrating the barriers to access created by intellectual property and the high prices normally associated with its exercise. Fourth, it presents the background, main aspects and obstacles to the achievement of the objectives of the Doha Declaration on the TRIPS Agreement and Public Health (2001). To conclude, this paper examines the experiences of compulsory licensing and government use of patents in Latin America (particularly in Ecuador, Peru AND Colombia).

Ketersediaan
08007346.048 CAR aPerpustakaan DJKI TangerangTersedia namun tidak untuk dipinjamkan - Tidak Bisa Dipinjam
Informasi Detail
Judul Seri
Research Paper
No. Panggil
346.048 CAR a
Penerbit
Geneva : South Centre.,
Deskripsi Fisik
36 hlm
Bahasa
English
ISBN/ISSN
ISSN 1819 - 6926
Klasifikasi
346.048
Tipe Isi
text
Tipe Media
other
Tipe Pembawa
-
Edisi
April 2019
Subjek
Medicines
Licenses
The Case of Hepatitis C
Info Detail Spesifik
Carlos M. Correa is Executive Director of the South Centre, Geneva. German Velasquez is Special Advisor, Policy and Health at the South Centre, Geneva
Pernyataan Tanggungjawab
Versi lain/terkait

Tidak tersedia versi lain

Lampiran Berkas
Tidak Ada Data
Komentar
Anda harus masuk sebelum memberikan komentar